Clinical Trial Results:
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Single Treatment Cycle, Parallel Evaluation of the Safety, Efficacy and Immunogenicity of Two Formulations of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex (Formulation Nos. 9060X and 9525X) Followed by a Blinded Active Treatment Extension of Up to Two Additional Treatment Cycles in Patients with Cervical Dystonia
Summary
|
|
EudraCT number |
2007-004530-16 |
Trial protocol |
CZ HU GB PT DE |
Global completion date |
28 Dec 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Nov 2016
|
First version publication date |
03 Nov 2016
|
Other versions |
|
Summary report(s) |
CT.gov Summary Results - Study 191622-090 - Eudra 2007-004530-16 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.